Lilly’s tirzepatide sheds lean muscle harder than Novo’s semaglutide, study suggests
研究显示，礼来旗下的tirzepatide较诺和诺德的司美格鲁肽更易导致瘦体重流失

While Eli Lilly’s tirzepatide helps patients drop more weight than Novo Nordisk’s semaglutide, this might come with greater loss in lean body mass, according to a new study awaiting peer review.
一项尚待同行评审的新研究指出，尽管礼来的tirzepatide帮助患者减重幅度超过诺和诺德的司美格鲁肽，但这可能伴随着更大的瘦体重流失。